Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow

The Annual Chemotherapy Foundation Symposium (CFS®), now in its 44th year, is a significant event dedicated to advancing the field of cancer therapy. This innovative conference gathers thousands of healthcare professionals, including oncologists, hematologists, nurses, advanced practice providers, pharmacists, radiotherapists, immunologists, fellows, researchers, and pathologists. The symposium serves as a vital platform for sharing evidence-based practices and the latest developments in cancer therapeutics, ultimately aiming to enhance clinical care for patients battling cancer.

Over the course of three days at the New York Hilton Midtown in New York, attendees will have the unique opportunity to gain expert insights from an internationally renowned faculty. The event will address the rapid changes and exciting new developments in the management of both solid and hematologic malignancies. Key topics include practice-changing diagnostic, therapeutic, and supportive care strategies that have emerged in the past year, as well as those set to enter clinical practice soon.

The CFS® emphasizes optimized testing and treatments for early and advanced disease, covering various modalities such as chemotherapeutics, targeted therapies, and immunotherapies, alone and in combination. This comprehensive approach aims to improve clinical outcomes and equip healthcare professionals with the critical knowledge to integrate these innovative strategies into their practices effectively.